| NITRIC OXIDE | None | ||
|
Less Than $1000 mn
|
|||
| None | None | ||
| None | None | ||
| None | None | ||
| GENOSYL is a vasodilator indicated to improve oxygenation and reduce the need for extracorporeal membrane oxygenation in term and near-term (>34 weeks gestation) neonates with hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension in conjunction with ventilatory support and other appropriate agents. | |||
|
Yes
| |||
| GENOSYL | Patent 1 | Patent 2 | Patent 3 | Patent 4 | Patent 5 | Patent 6 | Patent 7 | Patent 8 | Patent 9 | Patent 10 | Patent 11 | Patent 12 | Patent 13 | Patent 14 | Patent 15 | Patent 16 | Patent 17 | Patent 18 | Patent 19 | Patent 20 | Patent 21 | Patent 22 | Patent 23 | Patent 24 | Patent 25 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| *** ********* | |||||||||||||||||||||||||
| ********** ** ******** ******* (***) ** ****** ***** (**) | ********** ** ******** ******* (***) ** ****** ***** (**) | *** *** *** ********** ** ******** ******* (***) ** ****** ***** (**) | ********** ** ******** ******* (***) ** ****** ***** (**) | ******* *** ******* *** ********** ****** ***** | ******* *** ******* *** ********** ****** ***** | ******* *** ******* *** ********** ****** ***** | ********** ** ******** ******* (***) ** ****** ***** (**) | ******** ******* ******* ******** | ******** ******* ******* ****** | ******* *** ******* *** ********** ****** ***** | ****** ***** ********* | ********** ** ******** ******* (***) ** ****** ***** (**) | *****-** ********* *** ****** ***** ******** ****** | ****** ****** ***** ********* *** ********** ***/** ******* ******* ** ********* | ********** ** ******** ******* (***) ** ****** ***** (**) | ********** ** ******** ******* (***) ** ****** ***** (**) | ********** ** ******** ******* (***) ** ****** ***** (**) | ********** ** ******** ******* (***) ** ****** ***** (**) | ********** ** ******** ******* (***) ** ****** ***** (**) | ********** ** ******** ******* (***) ** ****** ***** (**) | ********** ** ******** ******* (***) ** ****** ***** (**) | ********** ** ******** ******* (***) ** ****** ***** (**) | ********** ** ******** ******* (***) ** ****** ***** (**) | ********** ** ******** ******* (***) ** ****** ***** (**) |
Download ParaIV Report
| Drug Name | Generic Name | Dosage | Route of Administration | Probable FTF | Known Para IV Filers | Other ANDA Developers |
|---|